siguazodan has been researched along with Anesthesia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coates, WJ; Dolan, JS; Grimsditch, D; Lamb, J; Murray, KJ; Turner, NC; Warrington, BH; Worby, A | 1 |
| Comer, MB; Eden, RJ; Gristwood, RW; Owen, DA; Taylor, EM; Turner, JA; Wallduck, M | 1 |
2 other study(ies) available for siguazodan and Anesthesia
| Article | Year |
|---|---|
Pulmonary effects of type V cyclic GMP specific phosphodiesterase inhibition in the anaesthetized guinea-pig.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Anesthesia; Animals; Bronchoconstriction; Cyclic GMP; Guanidines; Guinea Pigs; Male; Nitroprusside; Parasympatholytics; Phosphodiesterase Inhibitors; Purinones; Pyridazines; Pyrrolidinones; Rolipram; Trachea | 1994 |
In vivo pharmacological studies with SK&F 94836, a potent inotrope/vasodilator with a sustained duration of action.
Topics: Anesthesia; Animals; Cardiotonic Agents; Cats; Dogs; Female; Guanidines; Heart Rate; Hemodynamics; In Vitro Techniques; Male; Myocardium; Oxygen Consumption; Papaverine; Phosphodiesterase Inhibitors; Pyridazines; Vascular Resistance; Vasodilator Agents | 1988 |